Persistent Systems Ltd Q4 FY2024 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/a84eqii7emdomytlvlluhgdk.pdf

Key Takeaways


Margin Mechanics

Kalra: "Improving margin is an easier task versus getting higher growth. So, for this year we'll focus on growth and at any point in time if we can improve the margins, rest assured we'll do our best to improve the margins."

Top Customer & Client Concentration

Kalra: "So, some of the ramp downs are planned ramp downs. So, when we do larger deals, there are productivity things built year-on-year and so these are not any surprises. So, if there was any surprises that would have been told very clearly."

Vertical Performance

VerticalTrendCommentary
Healthcare & Life Sciences▲ Strong growthGrew 15% QoQ on a large win plus sustained momentum; team built over years; expected to lead FY25 growth.
BFSI▲ Incremental improvementGrew 2% QoQ; new logo ramp-ups should accelerate; Persistent positioned as a challenger where clients are fatigued with larger incumbents.
Hi-Tech & Emerging▼ Declined (headline)Declined 0.9% QoQ due to top customer ramp-down; ex-top-1 grew 1.6%. Enterprise software headwinds expected for next few quarters.

AI, GenAI & SASVA Platform

Kalra: "Our attempt here is not to use this as a product, but use this as an accelerator, as an IT that we will use so that we can retain the value and capture more value in services as we go around rather than just using it as another part of our Accelerite business or payments."

People, Capacity & Investments

Kalra: "Whether it is a bad economy or a good economy, we are preparing ourselves to go to $2 bn and much beyond."

Capital Allocation & Financial Position


Guidance & Commitments

CommitmentSpecificsTimeline
Medium-term margin expansionImprove margins by 200-300 bps from current levelsNext 2-3 years
FY25 growth trajectoryMaintain top-quartile, industry-leading growth while holding margins at current-year levelsFY25
Carbon neutralityAchieve carbon neutrality for Scope 1 & 2 emissions, 100% renewable energy sourcingMid-FY25
ETR rangeRemain at 24.5%FY25
Healthcare-led growthHealthcare to lead FY25 growth, followed by BFSI, then TechFY25
Hi-tech segment pressureEnterprise software headwinds to persistNext few quarters
Europe turnaroundTurn the corner on Europe growthNext several quarters

Key Metrics

MetricQ4 FY24
Revenue (USD)$310.9 million, +3.4% QoQ and +13.2% YoY
Revenue (INR)₹2,590.5 crore, +3.7% QoQ and +14.9% YoY
Constant currency revenue growth3.4% QoQ
EBIT margin14.45%, flat QoQ; one-time transition costs and lower utilization offset by earn-out liability reduction
Profit after tax₹315.32 crore, 12.2% of revenue
Earnings per share (FY24)₹144.87, +17.1% YoY on like-to-like ₹10 face value
Total contract value (TCV)$447.7 million, with new bookings TCV of $302 million
Annual contract value (ACV) from new bookings$184.5 million
Healthcare & Life Sciences revenue growth15% QoQ
BFSI revenue growth2% QoQ
Hi-Tech & Emerging vertical revenue growth-0.9% QoQ, +1.6% QoQ excluding top 1 customer
Top 10 client revenue contribution40% of revenue, first time since Q1 FY23
Total headcount23,850, net increase of 514 QoQ
Blended utilization80%, down from 81.5% in Q3
Trailing 12-month attrition11.5%, improved from 11.9% in Q3
Dividend per share (final, recommended)₹10 on face value of ₹5 per share; total FY24 dividend ₹52 per share
Days sales outstanding63 days, improved from 66 days in Q3
Operating cash flow to EBITDA0.76 for Q4, 0.73 for full year FY24